Stock Alerts
Adding Nektar call options to my Volatility Portfolio–again
Again. I'm adding the January 17, 2020 Call Options with a strike at $35 on Nektar Theraeutics (NKTR) to my Volatility Portfolio on JubakAM.com and JugglingWithKnives.com. (Ticker on these options is NKTR200117C00035000.) The underlying shares closed at $33.70, up...
I added Parsley Energy to my Jubak Picks Portfolio back on April 17–but neglected to post it to the portfolio
Back on April 17, I made Parsley Energy (PE) my first disruption in the oil sector pick in my Special Report on Disrupted Sectors. I didn't actually post that pick to the portfolio, however, and this post, excerpted from the Special Report, is a fix for that error....
Chip recovery keeps slipping further away, Broadcom says
Today Broadcom (AVGO) cut its annual sales forecast, saying that the U.S.-China trade war will wipe out the rebound in orders that it had predicted for the second half of 2019. Revenue at the chipmaker for fiscal 2019 will be $22.5 billion instead of the $24.5 billion...
Nektar Therapeutics bumps along ahead of August FDA action on new non-addictive opioid
Shares of Nektar Therapeutics (NKTR) have been bumping along between $32 and $34 for two months now, but the company continues to take steps to prepare for the likely August approval of NKTR-181, a new non-addictive opioid. Nektar has formed Inheris Biopharma, a...
Salesforce buys Tableau: Nobody wants to be a “dumb pipe”
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Evidence that Lions Gate Entertainment will work–with enough patience
Shares of Lions Gate Entertainment (LGF/A) are down 43.56% since I added them to my Jubak Picks Portfolio on June 14, 2018. The shares dropped another 3.4% on Friday back to $14.03. That pretty much erased the stock's gain from $13.02 on May 13 to $16.02 on May 22....
Adding Grupo Aeroportuario del PacÃfico to my Dividend Portfolio on Monday
Now that President Donald Trump's tariff threat isn't hanging over the Mexican economy (for the moment, anyway), I'm adding Grupo Aeroportuario del PacÃfico (PAC) to my Dividend Portfolio on Monday. The shares of Grupo Aeroportuario del Pacifico, which operates five...
Infineon’s acquisition of Cypress will create new No. 1 among auto chip suppliers
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Buying this Vanguard Treasury ETF on Monday for my ETF Portfolio–and for my Jubak Picks and Volatility portfolios
Today I sold the iShares MSCI Emerging Markets ETF (EEM) out of my Perfect 5 ETF Portfolio. And today I'm replacing it in that portfolio with the Vanguard Intermediate Term Treasury ETF (VGIT). Now obviously a Treasury bond ETF isn't in the same asset class as an...
Selling Emerging Markets ETF out of my ETF Portfolio on Monday
In an ideal world, I would have finished my Special Report on the Crisis in Global Capitalism On my subscription JubakAM.com site by now so I could place this sell--and the coming buy of a Treasury ETF--in the context of that crisis. But this isn't an ideal world....
Incyte adds to Jakafi label with new FDA approval
Jubak Picks and Volatility Portfolio member Incyte (INCY) closed up 1.55% today to $81.75 on news that the U.S. Food and Drug Administration had approved the company's Jakafi for treatment for acute Graft versus Host disease (GvHD), an inflammatory response by the...Jim’s Stock Alerts
Download Jim’s eBook for Free
